(주) 뷰노

BoneAge to become the first AI based software to receive approval for clinical trials

  • 2017. 09. 26

VUNO-Med BoneAge is the first AI based diagnostic device to receive approval for clinical trials in South Korea.

It is a bone age detection software based on the G.P. Atlas system developed in collaboration with Seoul Asan

Medical Center. Our product has been verified as a clinical support tool over the last few years and is expected

to become the first AI based diagnostic tool to receive KFDA clearance.


-


http://www.mdtoday.co.kr/mdtoday/index.html?no=297968